Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelets Discontinuation in Polypectomy
NCT02865824Unknown
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of clopidogrel, ticagrelor and prasugrel in cardiovascular diseases (CVD) (2 arms), sponsored by Incheon St. Mary's Hospital. Primary endpoint: Delayed bleeding requiring hemostasis after polypectomy at 2 weeks. Status: unknown.
02
Drugs
clopidogrelticagrelorprasugrel
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT02865824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865824.